Transforming Cancer Treatment Decisions

We extract unique information from biopsies to better

match the right patient to the right treatment and augment the pathologist

 

Our

Products

Pathology Automation
Treatment Prediction
 
 

Management

Team

Avi Veidman
CEO
Eliron Amir
CTO
Lotan Chorev
VP R&D
Arnon Horev
CBO

Clinical
Team

Eli Brazowski
M.D.
Pathologist in Residence 
Prof. Stanley J. Robboy, MD, FCAP
Advisor
Prof. Thomas Wheeler, MD
Advisor

Our Edge

Investors

 
 

Contact Us

© 2019 all rights reserved to Nucleai